197 related articles for article (PubMed ID: 33833369)
1. Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression.
Hoan NX; Huyen PTM; Binh MT; Trung NT; Giang DP; Linh BT; Dung DTN; Pallerla SR; Kremsner PG; Velavan TP; Bang MH; Song LH
Sci Rep; 2021 Apr; 11(1):7772. PubMed ID: 33833369
[TBL] [Abstract][Full Text] [Related]
2. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
[TBL] [Abstract][Full Text] [Related]
3. Circulating level of sPD-1 and PD-1 genetic variants are associated with hepatitis B infection and related liver disease progression.
Huyen PTM; Dung DTN; Weiß PJ; Hoan PQ; Giang DP; Uyen NT; Van Tuan N; Trung NT; Velavan TP; Song LH; Hoan NX
Int J Infect Dis; 2022 Feb; 115():229-236. PubMed ID: 34910956
[TBL] [Abstract][Full Text] [Related]
4. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
5. Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection.
Li Z; Li N; Zhu Q; Zhang G; Han Q; Zhang P; Xun M; Wang Y; Zeng X; Yang C; Liu Z
Infect Genet Evol; 2013 Mar; 14():240-6. PubMed ID: 23291409
[TBL] [Abstract][Full Text] [Related]
6. Association between catalase gene polymorphisms and risk of chronic hepatitis B, hepatitis B virus-related liver cirrhosis and hepatocellular carcinoma in Guangxi population: a case-control study.
Liu Y; Xie L; Zhao J; Huang X; Song L; Luo J; Ma L; Li S; Qin X
Medicine (Baltimore); 2015 Apr; 94(13):e702. PubMed ID: 25837767
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants of interferon regulatory factor 5 associated with chronic hepatitis B infection.
Sy BT; Hoan NX; Tong HV; Meyer CG; Toan NL; Song LH; Bock CT; Velavan TP
World J Gastroenterol; 2018 Jan; 24(2):248-256. PubMed ID: 29375210
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Dynamics of Programmed Death Ligand-1 Expression on Circulating CD14
Huang ZY; Xu P; Li JH; Zeng CH; Song HF; Chen H; Zhu YB; Song YY; Lu HL; Shen CP; Zhang XG; Wu MY; Wang XF
Viral Immunol; 2017 Apr; 30(3):224-231. PubMed ID: 28005469
[TBL] [Abstract][Full Text] [Related]
9. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in IL33 and IL1RL1 genes confer susceptibility to HBV-related liver cirrhosis in Chinese Han population.
Ma N; Xu M; Dong Y; Yu F; Zhang X; Gao X; Meng Y; Gao P; Zhou J; Yuan M; Mi Y; Qi S; Li L; Liu D; Liu W; Yang L
Infect Genet Evol; 2021 Oct; 94():104983. PubMed ID: 34197916
[TBL] [Abstract][Full Text] [Related]
11. The effects of the interactions of STAT4 rs7574865 with HBV mutations on the risk of hepatocellular carcinoma.
Yang C; Chen H; Zhou B; Yin J; Cao G; Hou J; Jiang D
Mol Carcinog; 2022 Oct; 61(10):933-940. PubMed ID: 35880842
[TBL] [Abstract][Full Text] [Related]
12. PD-1 mRNA expression is associated with clinical and viral profile and PD1 3'-untranslated region polymorphism in patients with chronic HBV infection.
Zhang G; Li N; Zhang P; Li F; Yang C; Zhu Q; Han Q; Lv Y; Zhou Z; Liu Z
Immunol Lett; 2014 Nov; 162(1 Pt A):212-6. PubMed ID: 25218665
[TBL] [Abstract][Full Text] [Related]
13. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
14. Association of PvuII and XbaI polymorphisms in estrogen receptor alpha gene with the risk of hepatitis B virus infection in the Guangxi Zhuang population.
Liu Y; Liu Y; Huang X; Sui J; Mo C; Wang J; Peng Q; Deng Y; Huang L; Li S; Qin X
Infect Genet Evol; 2014 Oct; 27():69-76. PubMed ID: 25014269
[TBL] [Abstract][Full Text] [Related]
15. Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma.
Li Z; Li N; Li F; Zhou Z; Sang J; Chen Y; Han Q; Lv Y; Liu Z
Medicine (Baltimore); 2016 Dec; 95(52):e5749. PubMed ID: 28033288
[TBL] [Abstract][Full Text] [Related]
16. Association of genetic polymorphisms in CD8+ T cell inhibitory genes and susceptibility to and progression of chronic HBV infection.
Peng H; Li QL; Hou SH; Hu J; Fan JH; Guo JJ
Infect Genet Evol; 2015 Dec; 36():467-474. PubMed ID: 26296604
[TBL] [Abstract][Full Text] [Related]
17. A Programmed Cell Death-1 Haplotype is Associated with Clearance of Hepatitis B Virus.
Hou Z; Zhou Q; Lu M; Tan D; Xu X
Ann Clin Lab Sci; 2017 May; 47(3):334-343. PubMed ID: 28667037
[TBL] [Abstract][Full Text] [Related]
18. SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B.
Hoan NX; Van Tong H; Giang DP; Cuong BK; Toan NL; Wedemeyer H; Bock CT; Kremsner PG; Song LH; Velavan TP
Oncotarget; 2017 Mar; 8(10):17127-17139. PubMed ID: 28179578
[TBL] [Abstract][Full Text] [Related]
19. Association of polymorphism rs1053005 in STAT3 with chronic hepatitis B virus infection in Han Chinese population.
Li M; Li F; Li N; Sang J; Fan X; Deng H; Zhang X; Han Q; Lv Y; Liu Z
BMC Med Genet; 2018 Apr; 19(1):52. PubMed ID: 29609539
[TBL] [Abstract][Full Text] [Related]
20. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
